Home / Veterinary / Diseases and genes

Neonatal cortical cerebellar abiotrophy (NCCD) — Hungarian Vizsla (SNX14)

Neurological · Dog

Neonatal cerebellar cortical degeneration of the Hungarian Vizsla (short- and wire-haired) due to a splice donor site mutation in SNX14, with loss of Purkinje cells. Typical ataxia begins around 3 months of age with relatively rapid progression: general incoordination, intention and head tremor, insufficient menace response and nystagmus. It is inherited in an autosomal recessive manner. It is molecularly distinct from Beagle NCCD (SPTBN2): each test is valid only for its breed.
Inheritance patternAutosomal recessive.
Gene / MutationSNX14 c.2653+1G>A (splice donor site mutation; Fenn et al. 2016). Distinct from Beagle NCCD (SPTBN2).
PenetranceComplete in homozygotes in the published cohort; heterozygotes asymptomatic. Data outside the cohort: limited.
Sample type0,5 - 1 ML Sangre EDTA o 2 Hisopos bucales sin medio de raspado intenso
Codenccv
Turnaround time7 days
Price36,05 €
BreedsVizsla húngaro (pelo corto y duro)

Incidence

Applicable breeds: short-haired and wire-haired Hungarian Vizsla. Carrier frequencies: limited data.

Clinical signs

- Cerebellar ataxia from ~3 months of age, with rapid progression\n- General incoordination and intention tremor\n- Head tremor and nystagmus\n- Insufficient menace response\n- Loss of Purkinje cells (cerebellar cortical degeneration)

History

Fenn et al. (2016) identified by whole-genome sequencing a splice donor site mutation in SNX14 (c.2653+1G>A) associated with a novel cerebellar cortical degeneration in the Hungarian Vizsla. It is distinct from Beagle NCCD (SPTBN2) and from other canine cerebellar abiotrophies.

Breeder management

- Test breeding animals (SNX14) before mating.\n- Do not cross two carriers: 25 %% risk of affected homozygotes.\n- A carrier can be crossed with a clear animal; test offspring intended for breeding.\n- Do not use the Beagle NCCD test (SPTBN2) in Vizslas or vice versa: they are different variants.\n- In cases of juvenile ataxia, include NCCD in the differential diagnosis.

Specialist notes

Differentiate from Beagle NCCD (SPTBN2, another test), from other cerebellar abiotrophies and from acquired causes (infectious, toxic, malformations). Diagnosis by clinical signs + molecular test; MRI shows cerebellar atrophy. No curative treatment.

References

1. Fenn J et al. 2016, el genoma revela mutación del sitio donador de SNX14 asociada a nueva degeneración cortical cerebelosa en Vizsla (PMID 27566131)

Add to cart

Price: 36,05 € · Turnaround time: 7 days

Add to cart

← Back to the search